Suppr超能文献

姜黄素的问题及其生物利用度:其胃肠道影响是否有助于其整体健康增强效果?

The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?

机构信息

School of Psychology and Exercise Science, Murdoch University, Perth, Western Australia, Australia.

出版信息

Adv Nutr. 2018 Jan 1;9(1):41-50. doi: 10.1093/advances/nmx011.

Abstract

Curcumin, from the spice turmeric, exhibits anti-inflammatory, antioxidant, anticancer, antiviral, and neurotrophic activity and therefore holds promise as a therapeutic agent to prevent and treat several disorders. However, a major barrier to curcumin's clinical efficacy is its poor bioavailability. Efforts have therefore been dedicated to developing curcumin formulations with greater bioavailability and systemic tissue distribution. However, it is proposed in this review that curcumin's potential as a therapeutic agent may not solely rely on its bioavailability, but rather its medicinal benefits may also arise from its positive influence on gastrointestinal health and function. In this review, in vitro, animal, and human studies investigating the effects of curcumin on intestinal microbiota, intestinal permeability, gut inflammation and oxidative stress, anaphylactic response, and bacterial, parasitic, and fungal infections are summarized. It is argued that positive changes in these areas can have wide-ranging influences on both intestinal and extraintestinal diseases, and therefore presents as a possible mechanism behind curcumin's therapeutic efficacy.

摘要

姜黄素是香料姜黄的主要成分,具有抗炎、抗氧化、抗癌、抗病毒和神经营养作用,因此有望成为预防和治疗多种疾病的治疗剂。然而,姜黄素临床疗效差的主要障碍是其生物利用度低。因此,人们致力于开发具有更高生物利用度和全身组织分布的姜黄素制剂。然而,在本综述中提出,姜黄素作为治疗剂的潜力可能不仅仅依赖于其生物利用度,其药用益处也可能源于其对胃肠道健康和功能的积极影响。在本综述中,总结了研究姜黄素对肠道微生物群、肠道通透性、肠道炎症和氧化应激、过敏反应以及细菌、寄生虫和真菌感染影响的体外、动物和人体研究。有人认为,这些领域的积极变化可能对肠道和肠道外疾病产生广泛影响,因此可能是姜黄素治疗功效的背后机制之一。

相似文献

3
[Advances in the research of protective effect of curcumin on intestinal mucosal barrier function].
Zhonghua Shao Shang Za Zhi. 2019 Feb 20;35(2):157-160. doi: 10.3760/cma.j.issn.1009-2587.2019.02.013.
4
The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective.
Crit Rev Food Sci Nutr. 2024;64(24):8822-8851. doi: 10.1080/10408398.2023.2204349. Epub 2023 Apr 25.
6
Advances in relieving exercise fatigue for curcumin: Molecular targets, bioavailability, and potential mechanism.
J Food Sci. 2024 Aug;89(8):4604-4619. doi: 10.1111/1750-3841.17162. Epub 2024 Jun 20.
9
Curcumin and neurodegenerative diseases: a perspective.
Expert Opin Investig Drugs. 2012 Aug;21(8):1123-40. doi: 10.1517/13543784.2012.693479. Epub 2012 Jun 6.
10
Pharmacokinetics and pharmacodynamics of curcumin.
Adv Exp Med Biol. 2007;595:453-70. doi: 10.1007/978-0-387-46401-5_20.

引用本文的文献

1
Autophagy in mycobacterial infections: molecular mechanisms, host-pathogen interactions, and therapeutic opportunities.
Front Cell Infect Microbiol. 2025 Aug 7;15:1640647. doi: 10.3389/fcimb.2025.1640647. eCollection 2025.
2
Curcumin and neuroplasticity: epigenetic mechanisms underlying cognitive enhancement in aging and neurodegenerative disorders.
Front Aging Neurosci. 2025 Aug 7;17:1592280. doi: 10.3389/fnagi.2025.1592280. eCollection 2025.
3
Enhancement of antioxidant and cytotoxicity by nanoliposome formulation of pentagamavunon-6 in breast cancer cells.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 23. doi: 10.1007/s00210-025-04533-w.
6
Integrative approaches in Alzheimer's disease: evaluating the potential of traditional, complementary, and integrative medicine (TCIM).
Front Pharmacol. 2025 Jun 30;16:1561702. doi: 10.3389/fphar.2025.1561702. eCollection 2025.
7
From Nature to Nanomedicine: Enhancing the Antitumor Efficacy of Rhein, Curcumin, and Resveratrol.
Medicina (Kaunas). 2025 May 26;61(6):981. doi: 10.3390/medicina61060981.
9
Beyond Conventional Treatments: The Role of Complementary Therapies in Head and Neck Cancer.
Cancers (Basel). 2025 Apr 9;17(8):1269. doi: 10.3390/cancers17081269.
10
Nano-based drug delivery systems for the treatment of non-infectious uveitis.
Adv Ophthalmol Pract Res. 2024 Nov 12;5(2):124-134. doi: 10.1016/j.aopr.2024.11.003. eCollection 2025 May-Jun.

本文引用的文献

1
Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
Psychosom Med. 2017 Oct;79(8):857-867. doi: 10.1097/PSY.0000000000000470.
2
Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction.
Cell Host Microbe. 2017 Apr 12;21(4):455-466.e4. doi: 10.1016/j.chom.2017.03.002.
4
A review on the relationship between gluten and schizophrenia: Is gluten the cause?
Nutr Neurosci. 2018 Sep;21(7):455-466. doi: 10.1080/1028415X.2017.1313569. Epub 2017 Apr 9.
5
Exercise Modifies the Gut Microbiota with Positive Health Effects.
Oxid Med Cell Longev. 2017;2017:3831972. doi: 10.1155/2017/3831972. Epub 2017 Mar 5.
6
Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats.
Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1801-1812. doi: 10.1016/j.bbagen.2017.03.017. Epub 2017 Mar 21.
7
The Microbiome and Host Behavior.
Annu Rev Neurosci. 2017 Jul 25;40:21-49. doi: 10.1146/annurev-neuro-072116-031347. Epub 2017 Mar 8.
8
[Effect of curcumin on intestinal mucosal mechanical barrier in rats with non-alcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):134-138. doi: 10.3760/cma.j.issn.1007-3418.2017.02.011.
9
Curcumin improves intestinal barrier function: modulation of intracellular signaling, and organization of tight junctions.
Am J Physiol Cell Physiol. 2017 Apr 1;312(4):C438-C445. doi: 10.1152/ajpcell.00235.2016. Epub 2017 Mar 1.
10
Mental Health Disorders Associated with Foodborne Pathogens.
J Food Prot. 2016 Nov;79(11):2005-2017. doi: 10.4315/0362-028X.JFP-15-587.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验